MENU

Joshua E. Meyer, MD

Joshua Meyer, MD

Clinical Locations

Primary Location

Fox Chase Cancer Center
333 Cottman Avenue
Philadelphia, PA 19111

About

Associate Professor, Radiation Oncology

Director, Radiation Oncology Residency and Fellowship Training Program

TRDG Member, Colorectal and SI CancerEsophagus, Pancreas, and Liver Cancer; Sarcoma and GIST Cancer

Treatment Focus

Stereotactic Body Radiation Therapy (SBRT), Intensity Modulated Radiation Therapy (IMRT), Image-Guided Radiation Therapy (IGRT), Radioembolization, MR-guided Focused Ultrasound, Re-irradiation, Pulsed Low Dose Rate (PLDR) radiation, Brachytherapy, Anal Cancer

Research Program

Treatment Philosophy

As technologies and treatments continue to advance, there are more and more options in the details of how each cancer patient is treated. I work with my colleagues in other disciplines to define the most appropriate treatment for each individual patient. For each individual I am treating with radiation, I make a concerted effort to survey the landscape of potential treatment choices that I am able to bring to a particular patient’s care to ensure that the most effective, precise and targeted approach is being used in every situation. This allows patients to get the maximum amount of benefit from treatment with as small a risk of complications as possible. 

Education, Training & Credentials

Educational Background

  • Resident, Stich Radiation Center, Weill Cornell Medical Center, New York, NY
  • MD, University of Massachusetts Medical School, Worcester, MA, 2005
  • BA, Haverford College, Haverford, PA, 1998

Certifications

  • Board Certified, Radiation Oncology, American College of Radiology, 2011

Memberships

  • American College of Radiology (ACR)
  • American Society of Clinical Oncology (ASCO)
  • American Society of Therapeutic Radiation Oncology (ASTRO)

Honors & Awards

  • ARRO Educator of the Year, 2015
  • Clinical Fellow, ASCO/AACR Workshop on Methods in Clinical Cancer Research, 2009
  • Roentgen Resident/Fellow Research Award, 2009
  • Lang Research Award, New York Hospital of Queens Residents and Fellows Day, 2009
  • American Radium Society Travel Grant, 2009
  • ASCO Cancer Foundation Merit Award, American Society of Clinical Oncology, 2009
  • International Society of Gastrointestinal Oncology Conference Educational Grant, 2008
Patient Stories

Mahmood Saeed

Kidney Cancer

Mahmood Saeed

Kidney Cancer

After being diagnosed with Stage 4 renal cell carcinoma, Mahmood Saeed sought treatment at Fox Chase Cancer Center. Prior to Fox Chase, other doctors only gave him a 5 percent chance of survival, but Fox Chase gave him hope. Today he takes a daily targeted therapy to keep the tumors from spreading; this treatment has greatly improved his quality of life. "I wouldn’t be here today without Dr. Reddy, my wife, and my faith," Mahmood said. "For my family, it wasn’t just one procedure or one doctor that led to healing—rather, it was the culmination of a healthy diet, support from family and friends, a positive attitude, and doctors working together as a team."

Melissa Kartasevich

Pancreatic Cancer

Melissa Kartasevich

Pancreatic Cancer

In 2013, at age 38, Melissa Kartasevich was enjoying life, raising her six-year-old daughter, and engaged to be married when she was shocked to be diagnosed with pancreatic cancer. Growing up near Fox Chase Cancer Center, she did not hesitate to seek treatment there. Melissa underwent chemotherapy and radiation, before having surgery to remove the tumor. The surgery was a success, but then in March 2016, the cancer returned, this time in her fallopian tube. She is currently on a clinical trial, but has hope she will beat cancer for the second time. "My motto is: 'Never, ever give up.' Be sure that you have a good feeling about your doctors because if you don’t like your doctors or your nurses, then it might not be the place or the doctor for you," Melissa said. "Advocate for yourself: Educate yourself on your diagnosis, and learn how you can help yourself and help the doctors help you."

Carol Hobson

Liver, Gall Bladder & Bile Duct Cancer

Carol Hobson

Liver, Gall Bladder & Bile Duct Cancer

After a doctor suspected she had bile duct cancer, Carol Hobson sought the help of specialists at Fox Chase Cancer Center, where a diagnosis of bile duct cancer was finally confirmed after extensive testing. In 2011, she underwent a bile duct resection, followed by chemotherapy and radiation therapy. The treatment was successul, and today Carol has extensive CAT scans and blood work done every three months to check for a possible recurrence. "I can tell you that if you decide to go to Fox Chase, you will get the most knowledgeable people taking care of you. Just as important, you will become part of the Fox Chase family and will be treated like a family member," she said. "That is one of the most outstanding features of Fox Chase Cancer Center."

Brooke Fuller

Colorectal Cancer

Brooke Fuller

Colorectal Cancer

Brooke Fuller enjoys working as a floral designer. She and her husband, Scott, are parents to one five-year-old son, Pierce. In January, 2014, at age 30, Brooke was diagnosed with stage 2 colorectal cancer.

James Ferraro

Esophageal Cancer

James Ferraro

Esophageal Cancer

James Ferraro was 61 in 2010 when he was diagnosed with esophageal cancer, after a chocking incident that had occurred. His niece had a friend who worked in research for Fox Chase Cancer Center, and recommended James seek treatment there. At Fox Chase, he underwent both chemotherapy and radiation, while staying at the Hope Lodge along with his wife. James later underwent a successful 10-hour surgical procedure to remove any suspicious areas of his esophagus. Today, he continues to do well and is happy to be back to the activities he always enjoyed. "The doctors at Fox Chase are truly my heroes," he said. "I plan on living for a long time and enjoying every day of my life."

Pages

Research Profile

Research Program

Research Interests

My interests are in clinical research for gastrointestinal cancers. This includes the new application of radiation technology to increase surgical resectability and cure rates. It also includes outcomes work to determine which management strategies are the most effective for these patients.

Publications

Selected Publications

LS Wang, T Shaikh, EA Handorf, JP Hoffman, SJ Cohen, JE Meyer. Dose Escalation With a Vessel Boost in Borderline Resectable Pancreatic Adenocarcinoma Treated With Neoadjuvant Chemoradiation. Practical  Radiation Oncology  90(1); 2015. PubMed

Shaikh T, Ruth K, Scoot WJ, Burtness BA, Cohen SJ, Konski AA, Cooper HS, Astsaturov I, Meyer JE.  “Increased time from neoadjuvant chemoradiation to surgery is associated with higher pathologic complete response rates in esophageal cancer.”  Ann Thorac Surg, 99(1):270-6, 2015 PubMed

Meyer JE, Panico VJ, Marconato HM, Sherr DL, Christos P, Pirog EC. “HIV positivity but not HPV/p16 status is associated with higher recurrence rate in anal cancer.” J Gastrointest Cancer, 44(4):450-5; 2013. PubMed

Meyer JE, Cohen SJ. “Beyond First-Line Therapy: Combining Chemotherapy and Radioembolization for Hepatic Colorectal Metastases.” J Nucl Med Radiat Ther  2:1-6; 2011 

Meyer JE, Sherr DL. “Reply to receptive anal intercourse as a potential risk factor for rectal cancer.” Cancer.  117:3284-5; 2011.

Meyer JE, Narang T, Schnoll-Sussman FH, Pochapin MB, Christos PJ, Sherr DL. “Increasing incidence of rectal cancer in patients aged younger than 40 years.” Cancer. 116:4354-9; 2010. PubMed

Meyer JE, Sherr DL. “When Less Is More, When Less Is Less: Local Excision in Early Rectal Cancer.” Gastrointest Cancer Res. 3(3): 123-4; 2009. PubMed

Fitzgerald TJ, Simon E, Meyer JE.  “Prostate carcinoma: opportunities for translational research”  J Cell Biochem 91(3):433-42, 2004. PubMed

Additional Publications

My NCBI